Recombinant human factor VIIa (rFVIIa) in a rabbit stasis model

This publication has 10 references indexed in Scilit:

• Factor IX is activated in vivo by the tissue factor mechanism
  Blood, 1990
• Factor VIIa-catalyzed activation of factor X independent of tissue factor: its possible significance for control of hemophilic bleeding by infused factor VIIa
  Blood, 1990
• Mechanism by which recombinant factor VIIa shortens the aPTT: Activation of factor X in the absence of tissue factor
  Thrombosis Research, 1989
• Use of recombinant activated factor VII for treatment of a retropharyngeal hemorrhage in a hemophilic patient with a high titer inhibitor
  American Journal of Hematology, 1989
• SUCCESSFUL USE OF RECOMBINANT FACTOR VIIa IN PATIENT WITH SEVERE HAEMOPHILIA A DURING SYNOVECTOMY
  The Lancet, 1988
• Coagulation Factor IX concentrate: method of preparation and assessment of potential in vivo thrombogenicity in animal models
  Blood, 1984
• The coagulant-active phospholipid content is a major determinant of in vivo thrombogenicity of prothrombin complex (Factor IX) concentrates in rabbits
  Blood, 1982
• [19] Human factor VII
  Published by Elsevier ,1981
• Activated factor VII: presence in factor IX concentrates and persistence in the circulation after infusion
  Blood, 1979
• The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity.
  Journal of Clinical Investigation, 1976